Search research articles
Contact Us
Filters
Showing results (141-150 of 218) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531
Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Chromatin Profiling of CBFA2T3-GLIS2 AMLs Identifies Key Transcription Factor Dependencies and BRG1 Inhibition as a Novel Therapeutic Strategy
Samantha Kaonis, Jenny L Smith, Neerja Katiyar, et al.
Blood
|
March 3, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
Marco Becilli, Pietro Merli, Mattia Algeri, et al.
Blood
|
December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Mignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Oncotarget
|
June 15, 2018
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling
Katherine Tarlock, Shan Zhong, Yuting He, et al.
Cytometry. Part B, Clinical Cytometry
|
July 12, 2019
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Laura M Pardo, Andrew P Voigt, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2019
Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia
Katherine Tarlock, Todd A Alonzo, Yi-Cheng Wang, et al.
Blood
|
July 15, 2004
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes
Norman J Lacayo, Soheil Meshinchi, Paivi Kinnunen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2013
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy
Leslie Mortland, Todd A Alonzo, Roland B Walter, et al.
Blood
|
April 27, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study
Jasmijn D E de Rooij, Riccardo Masetti, Marry M van den Heuvel-Eibrink, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 218) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531
Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Biorxiv : the Preprint Server for Biology
|
September 11, 2023
Chromatin Profiling of CBFA2T3-GLIS2 AMLs Identifies Key Transcription Factor Dependencies and BRG1 Inhibition as a Novel Therapeutic Strategy
Samantha Kaonis, Jenny L Smith, Neerja Katiyar, et al.
Blood
|
March 3, 2026
Anti-CD7 fratricide-resistant chimeric antigen receptor T cells for relapsed/refractory acute myeloid leukemia
Marco Becilli, Pietro Merli, Mattia Algeri, et al.
Blood
|
December 3, 2003
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Mignon L Loh, Shashaank Vattikuti, Suzanne Schubbert, et al.
Oncotarget
|
June 15, 2018
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling
Katherine Tarlock, Shan Zhong, Yuting He, et al.
Cytometry. Part B, Clinical Cytometry
|
July 12, 2019
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group
Laura M Pardo, Andrew P Voigt, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 12, 2019
Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia
Katherine Tarlock, Todd A Alonzo, Yi-Cheng Wang, et al.
Blood
|
July 15, 2004
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes
Norman J Lacayo, Soheil Meshinchi, Paivi Kinnunen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2013
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy
Leslie Mortland, Todd A Alonzo, Roland B Walter, et al.
Blood
|
April 27, 2016
Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study
Jasmijn D E de Rooij, Riccardo Masetti, Marry M van den Heuvel-Eibrink, et al.
Page
of 22